Reference (Jun-21-A6)

biotalkm

June 20, 2021135 views0

[1]       Kolba MD, Dudka W, Zaręba-Kozioł M, et al. 2019 Tunneling nanotube-mediated intercellular vesicle and protein transfer in the stroma-provided imatinib resistance in chronic myeloid leukemia cells. Cell Death Dis.;10(11):817. doi:10.1038/s41419-019-2045-8

[2]       Panasiuk M, Rychłowski M, Derewońko N, Bieńkowska-Szewczyk K. 2018 Tunneling Nanotubes as a Novel Route of Cell-to-Cell Spread of Herpesviruses. SandriGoldin RM, ed. J Virol.;92(10):1-17. doi:10.1128/JVI.00090-18

[3]       Lou E, Fujisawa S, Barlas A, et al. 2012 Tunneling Nanotubes. Commun Integr Biol.;5(4):399-403. doi:10.4161/cib.20569

[4]       Pinto G, Brou C, Zurzolo C. 2020 Tunneling Nanotubes: The Fuel of Tumor Progression? Trends in Cancer.;6(10):874-888. doi:10.1016/j.trecan.2020.04.012

[5]       Dupont M, Souriant S, Lugo-Villarino G, Maridonneau-Parini I, Vérollet C. 2018 Tunneling Nanotubes: Intimate Communication between Myeloid Cells. Front Immunol.;9(JAN):1-6. doi:10.3389/fimmu.2018.00043

[6]       Zhu C, Shi Y, You J. Immune Cell Connection by Tunneling Nanotubes: The Impact of Intercellular Cross-Talk on the Immune Response and Its Therapeutic Applications. 2021Mol Pharm.;18(3):772-786. doi:10.1021/acs.molpharmaceut.0c01248

[7]       Han X, Wang X. Opportunities and challenges in tunneling nanotubes research: How far from clinical application? 2021 Int J Mol Sci. ;22(5):1-15. doi:10.3390/ijms22052306

[8]      Austefjord MW, Gerdes H-H, Wang X. Tunneling nanotubes. Commun Integr Biol. 2014;7(1):e27934. doi:10.4161/cib.27934